Stay updated on SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial

Sign up to get notified when there's something new on the SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page's revision label was updated to v3.6.6, replacing the previous v3.6.5. This indicates a minor maintenance update without changes to study details or patient-facing information.
    Difference
    0.0%
    Check dated 2026-09-01T19:13:27.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Adds a new funding identifier: '2017 ( U.S. NIH Grant/Contract )'. This expands the list of study identifiers with a funding source reference associated with the trial record.
    Difference
    0.0%
    Check dated 2026-08-25T20:07:48.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.4 to v3.6.5, indicating a new deployment of the page template. No study content or visible information appears to have changed.
    Difference
    0.0%
    Check dated 2026-08-11T19:51:48.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page revision label changed from v3.6.3 to v3.6.4, indicating a backend update to the page. No study data, details, or actionable content were altered.
    Difference
    0.0%
    Check dated 2026-07-21T13:41:50.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    The study page shows a revision badge updated from v3.6.0 to v3.6.3, indicating a newer revision of the document.
    Difference
    0.0%
    Check dated 2026-06-30T02:25:38.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    The page now includes an enrollment status note 'No longer looking for participants' and adds user help/navigation sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. The Intervention/Treatment heading formatting is updated and the revision tag changes from v3.5.5 to v3.6.0.
    Difference
    0.3%
    Check dated 2026-06-15T21:58:31.000Z thumbnail image

Stay in the know with updates to SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial page.